Related Experiment Video
Updated: Jul 29, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Panantiviral agents: implications for treating cancers associated with oncoviruses
Amna Siddiqui1, Syeda Ilsa Aaqil2, Areesha Jawed3
1Department of Medicine, Karachi Medical & Dental College, Karachi, Pakistan.
Abstract:
Tweetable abstract Panantiviral agents have emerged as a promising class of drugs for cancer therapy, targeting multiple oncoviruses simultaneously. Challenges include drug resistance, safety and developing specific inhibitors. Future research should focus on viral transcription regulators and new panantivirals. #cancer #oncovirus #panantiviral #drugresistance.
Related Concept Videos
Mechanisms of Retrovirus-induced Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Treatment Resistant Cancers
Subviral Agents
Tumor Immunotherapy

